DS
RPTP

David Shaw’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

David Shaw’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,000
Closed -$790K – 4135
2015
Q2 		$790K Buy
+50,000
New +$607K ﹤0.01% 2868

David Shaw's RPTP Position: Q4 2016 in Review

David Shaw sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 931,488 shares — an estimated $8.36M sold.

David Shaw first reported a position in RPTP in Q3 2013 and held it in 13 quarters. The position peaked at $35.2M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • David Shaw reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • David Shaw sold 931,488 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $8.36M.
  • David Shaw first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 13 quarters.
  • David Shaw's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $35.2M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.